| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/15/2014 | CN102146418B Recombinant II type herpes simplex virus vector, preparation method of recombinant II type herpes simplex virus vector, recombinant virus, medicinal composition and application |
| 01/15/2014 | CN102078290B Method for preparing carbonate lidocaine injection |
| 01/15/2014 | CN102038715B Traditional Chinese medicine dispersible tablet and preparation method thereof |
| 01/15/2014 | CN101757609B Method for controlling residue of organic solvent in thymic peptide alpha1 microballoon |
| 01/15/2014 | CN101580547B Hasylated polypeptides, especially hasylated erythropoietin |
| 01/15/2014 | CN101559041B Polypeptide medicament sustained release microsphere or microcapsule preparation with uniform grain size and preparation method thereof |
| 01/15/2014 | CN101557828B Preparations of phospholipids and pharmaceuticals containing 5-amino salicylic acid for the treatment of inflammatory bowel disease |
| 01/14/2014 | US8630720 Implantable device using ultra-nanocrystalline diamond |
| 01/14/2014 | US8629186 Polymer micelles containing anthracyclines for the treatment of cancer |
| 01/14/2014 | US8629184 Topical formulations for treatment of neuropathy |
| 01/14/2014 | US8629179 Methods and devices for providing prolonged drug therapy |
| 01/14/2014 | US8629177 Nanoencapsulated delta-9-tetrahydrocannabinol |
| 01/14/2014 | US8629160 Alkaloid aminoester derivatives and medicinal composition thereof |
| 01/14/2014 | US8629128 Vitamin formulation |
| 01/14/2014 | US8629111 Methods of providing therapeutic effects using cyclosporin components |
| 01/14/2014 | US8628964 Fetal pulmonary cells and uses thereof |
| 01/14/2014 | US8628937 Vaccines with enhanced immune response and methods for their preparation |
| 01/14/2014 | US8628851 Method for encapsulating a liquid |
| 01/14/2014 | US8628802 Continuous process for microspheres production by using expanded fluids |
| 01/14/2014 | US8628801 Pegylated nanoparticles |
| 01/14/2014 | US8628800 Non-adhesive elastic gelatin matrices |
| 01/14/2014 | US8628799 Coated tablet formulation and method |
| 01/14/2014 | US8628798 Water-swellable polymers |
| 01/14/2014 | US8628797 Oral extended-release composition |
| 01/14/2014 | US8628796 Room-temperature stable dronabinol formulations |
| 01/14/2014 | US8628795 Transdermal therapeutic buprenorphine system |
| 01/14/2014 | US8628794 Palatable ductile chewable veterinary composition |
| 01/14/2014 | US8628793 NGNA compositions and methods of use |
| 01/14/2014 | US8628789 Strong reversible hydrogels |
| 01/14/2014 | US8628754 Highly efficient delivery of a large therapeutic mass aerosol |
| 01/14/2014 | US8628517 Micro-fluidic device for drug delivery |
| 01/14/2014 | US8628493 Flexible spirally-rolled polymer tube for monitoring and treatment of brain injuries |
| 01/14/2014 | US8627818 Sealed capsule including an integrated puncturing mechanism |
| 01/14/2014 | CA2713673C Agent for enhancing anti-tumor effect comprising oxaliplatin liposome preparation, and anti-tumor agent comprising the liposome preparation |
| 01/14/2014 | CA2669019C Oral care compositions containing combinations of anti-bacterial and host-response modulating agents |
| 01/14/2014 | CA2582150C Modified release ibuprofen dosage form |
| 01/14/2014 | CA2566153C Foamed cleanser with suspended particles, a method of producing same and a dispenser therefore |
| 01/14/2014 | CA2548771C A medical solution, a method for producing said medical solution and use thereof |
| 01/14/2014 | CA2490147C Liquid dosage forms of non-enterically coated proton pump inhibitors |
| 01/14/2014 | CA2439925C Hydrogels that undergo volumetric expansion in response to changes in their environment and their methods of manufacture and use |
| 01/14/2014 | CA2373375C Combination of lactic acid bacteria and its use for the prevention and/or treatment of infections and inflammatory conditions |
| 01/14/2014 | CA2342243C Stable liquid formulations of botulinum toxin |
| 01/09/2014 | WO2014008503A1 Methods of using ceo2 and tio2 nanoparticles in modulation of the immune system |
| 01/09/2014 | WO2014008469A2 Methods of treating arthritis |
| 01/09/2014 | WO2014008432A1 Cryopreservation of cells inside a macro-encapsulation device |
| 01/09/2014 | WO2014008334A1 Stable non-aggregating nucleic acid lipid particle formulations |
| 01/09/2014 | WO2014008283A2 Biodegradable polymeric buffers |
| 01/09/2014 | WO2014007972A2 Epinephrine nanoparticles, methods of fabrication thereof, and methods for use thereof for treatment of conditions responsive to epinphrine |
| 01/09/2014 | WO2014007821A1 Compositions and methods for detecting anastomosis leakage |
| 01/09/2014 | WO2014007781A2 Inhalation compositions |
| 01/09/2014 | WO2014007780A1 Orally-disintegrating formulations of dexketoprofen |
| 01/09/2014 | WO2014007779A1 Orally-disintegrating formulations of dexketoprofen |
| 01/09/2014 | WO2014007778A1 COMBINED IMMEDIATE RELEASE FORMULATIONS OF NSAIDs |
| 01/09/2014 | WO2014007777A1 Combined capsule formulations of nsaids |
| 01/09/2014 | WO2014007776A1 Antispasmodic modified release formulations |
| 01/09/2014 | WO2014007775A1 A novel formulation having fast dissolution |
| 01/09/2014 | WO2014007774A1 Water soluble formulations comprising a piperidine derivative active agent |
| 01/09/2014 | WO2014007773A1 Compositions comprising muscarinic receptor antagonist and sorbitol |
| 01/09/2014 | WO2014007772A2 Inhalation compositions comprising glucose anhydrous |
| 01/09/2014 | WO2014007771A2 Inhalation compositions comprising muscarinic receptor antagonist |
| 01/09/2014 | WO2014007770A2 Inhalation compositions comprising corticosteroid and sorbitol |
| 01/09/2014 | WO2014007769A1 Compositions comprising muscarinic receptor antagonist and glucose anhydrous |
| 01/09/2014 | WO2014007768A1 Dry powder inhaler compositions comprising long acting muscorinic antagonists |
| 01/09/2014 | WO2014007767A1 Dry powder inhalers comprising a carrier other than lactose and a ternary component |
| 01/09/2014 | WO2014007766A1 Dry powder inhalers comprising a carrier other than lactose |
| 01/09/2014 | WO2014007597A1 Preparation for percutaneous absorption containing rotigotine |
| 01/09/2014 | WO2014007579A1 Transdermally absorbable preparation containing rotigotine |
| 01/09/2014 | WO2014007517A1 Ph sensitive fluorescent polydiacetylene liposome and drug delivery vehicle comprising same |
| 01/09/2014 | WO2014007463A1 Orally administered preparation whereby bioavailability of megestrol acetate is improved and method for improving bioavailability of orally administered megestrol acetate |
| 01/09/2014 | WO2014007266A1 Transdermal cancer antigen peptide preparation |
| 01/09/2014 | WO2014007239A1 Composition containing amphotericin b |
| 01/09/2014 | WO2014007065A1 Solid pharmaceutical tablet, and method for producing same |
| 01/09/2014 | WO2014006867A1 Composition containing biologically active substance |
| 01/09/2014 | WO2014006636A2 Stable compositions of fesoterodine |
| 01/09/2014 | WO2014006635A2 Solid oral compositions of silodosin |
| 01/09/2014 | WO2014006576A1 Pharmaceutical compositions comprising rifaximin and amino acids, preparation method and use thereof |
| 01/09/2014 | WO2014006571A2 Extended-release pharmaceutical dosage forms of carbidopa and levodopa and processes of preparation thereof |
| 01/09/2014 | WO2014006532A1 Capsules containing thymoquinone |
| 01/09/2014 | WO2014006261A2 Microparticles for encapsulating probiotics, production and uses thereof |
| 01/09/2014 | WO2014006215A1 Hydrogel vaccine formulations |
| 01/09/2014 | WO2014006202A1 A topical composition comprising a film-forming polymer for delivering an active ingredient to skin |
| 01/09/2014 | WO2014006201A1 A topical composition comprising a film-forming polymer for delivering an active ingredient to skin |
| 01/09/2014 | WO2014006110A1 Use of an inhibitor of irs-1 for treating skin disorders |
| 01/09/2014 | WO2014006004A1 Abuse deterrent pharmaceutical compositions for controlled release |
| 01/09/2014 | WO2014005934A1 Pharmaceutical administration forms comprising 5-chloro-n-({(5s)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-1,3-oxazolidin-5-yl}methyl)-2-thiophenecarboxamide |
| 01/09/2014 | WO2014005728A1 Syringe |
| 01/09/2014 | WO2014005606A1 Stable injectable pharmaceutical composition of neurokinin 1 receptor antagonist and process for preparation thereof |
| 01/09/2014 | WO2014005424A1 Formula of and method for preparing hair-darkening chinese medicine preparation |
| 01/09/2014 | WO2014005423A1 Hair-growing preparation and preparation method therefor |
| 01/09/2014 | WO2014005363A1 2,2',6,6'-tetraisopropyl-4,4'-2-biphenol soft capsule and method for preparing same |
| 01/09/2014 | WO2014005314A1 Bone-targeted delivery system for osteogenesis treatment based on small nucleic acid medicine and preparation method thereof |
| 01/09/2014 | WO2013175508A3 Stable pharmaceutical composition of aripiprazole |
| 01/09/2014 | WO2013171204A3 Ophthalmological vehicle system |
| 01/09/2014 | WO2013169977A3 Controlled release solid dose form |
| 01/09/2014 | WO2013141759A3 Use of l-carnosine for the preparation of a nanopreparation having an antihypoxic and antioxidant activity |
| 01/09/2014 | WO2013001309A3 Microbubble generation |
| 01/09/2014 | US20140012342 Apparatus and methods using acoustic telemetry for intrabody communications |
| 01/09/2014 | US20140011893 Composition and method |
| 01/09/2014 | US20140011891 MODIFICATIONS OF SOLID 3-sn-PHOSPHOGLYCERIDES |
| 01/09/2014 | US20140011885 Organic Compounds |